Clinical studies recruiting near Darlinghurst

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Kinghorn Cancer Centre · Hoffmann-La Roche · NCT06793215 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Skin & Cancer Foundation - The Skin Hospital · Takeda · NCT07244263 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Gilead Sciences · NCT07645287 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · St Vincent's Hospital Sydney Limited · Bristol-Myers Squibb · NCT06976216 A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbec
Phase 1/Phase 2 · SK Bioscience Co., Ltd. · NCT07280858 A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic P
Phase 1 · St Vincent's Hospital Sydney · Genentech, Inc. · NCT05800665 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · St Vincent's Hospital Sydney · BioNTech SE · NCT07070232 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults a
Phase 3 · GSK Investigational Site · ViiV Healthcare · NCT07650916 A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combinatio
Phase 1 · St Vincents Sydney · Vividion Therapeutics, Inc. · NCT06004245 Magnetic Resonance Imaging (MRI) Guided Stereotactic Adaptive Radiotherapy for Targeting Abdominal Cancer
NA · GenesisCare - St Vincent's Sydney · Australasian Gastro-Intestinal Trials Group · NCT06604533 Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Phase N/A · Cardiac Transplantation Laboratory, The Victor Chang Cardiac · University of Alberta · NCT02670408 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · St Vincent's Hospital Sydney · Corvus Pharmaceuticals, Inc. · NCT06561048 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414 Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
Phase 1/Phase 2 · St Vincent's Hospital · Immunocore Ltd · NCT06840119 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Phase 1 · Kinghorn Cancer Centre · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06343402 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing So
Phase 1 · The Kinghorn Cancer Centre · Myeloid Therapeutics · NCT07334119 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Kinghorn Cancer Centre · Hoffmann-La Roche · NCT05894239 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder
Phase 2 · East Sydney Doctors · HB BioTech, LLC · NCT07499440 A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06897930 An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
Phase 1/Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06617793 TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07223203 A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 · St Vincent s Hospital Sydney · Janssen Research & Development, LLC · NCT07518186 Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Phase 3 · The Skin Hospital · Regeneron Pharmaceuticals · NCT06585410 Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Phase 2 · St. Vincent's Hospital · Iovance Biotherapeutics, Inc. · NCT04614103 A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Phase 1 · Skin & Cancer Foundation Australia - The Skin Hospital · Forte Biosciences, Inc. · NCT06905873 A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 i
Phase 3 · Kinghorn Cancer Centre · Incyte Corporation · NCT07284849

Look up another city

Look up another condition